Stefano Malvolti

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 9

Top Venues

Vaccines

PLoS neglected tropical diseases

Expert review of vaccines

BMJ global health

MMGH Consulting

This page only lists publications with an associated author ORCID identifier.

Affiliation History

MMGH Consulting Jan 01 2017

Switzerland

Managing Director

UNIVAC SA May 01 2016 - Dec 31 2016

Belgium

CEO

GAVI Alliance Nov 01 2012 - Apr 30 2016

Switzerland

Director Vaccine Implementation

Novartis Mar 01 2011 - Oct 01 2012

Switzerland

Director Global Policy

PATH Mar 01 2009 - Mar 01 2011

United States

Director Strategic Vaccine Supply

Publications

Stefano Malvolti, Adam Soble, Paul Bloem, D Scott LaMontagne, Rakesh Aggarwal, Punnee Pitisuttithum, Helen Rees, Tania Cernuschi
The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines 12 (1) (2023)
Stefano Malvolti, Adam Soble, Paul Bloem, D Scott LaMontagne, Rakesh Aggarwal, Punnee Pitisuttithum, Helen Rees, Tania Cernuschi
The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines 12 (1) (2023)
Stefano Malvolti, Adam Soble, Paul Bloem, D Scott LaMontagne, Rakesh Aggarwal, Punnee Pitisuttithum, Helen Rees, Tania Cernuschi
The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines 12 (1) (2023)
Stefano Malvolti, Adam Soble, Paul Bloem, D Scott LaMontagne, Rakesh Aggarwal, Punnee Pitisuttithum, Helen Rees, Tania Cernuschi
The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer. Vaccines 12 (1) (2023)
Han Fu, Kaja M Abbas, Stefano Malvolti, Christopher Gregory, Melissa Ko, Jean-Pierre Amorij, Mark Jit
Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation. BMJ global health 8 (11) (2023)
Sakshi Mohan, Paul Revill, Stefano Malvolti, Melissa Malhame, Mark J Sculpher, Paul M Kaye
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates. PLoS neglected tropical diseases 16 (6) (2022)
Stefano Malvolti, Melissa Malhame, Carsten F Mantel, Epke A Le Rutte, Paul M Kaye
Human leishmaniasis vaccines: Use cases, target population and potential global demand. PLoS neglected tropical diseases 15 (9) (2021)
Paul M Kaye, Sakshi Mohan, Carsten Mantel, Melissa Malhame, Paul Revill, Epke Le Rutte, Vivak Parkash, Alison M Layton, Charles J N Lacey, Stefano Malvolti
Overcoming roadblocks in the development of vaccines for leishmaniasis. Expert review of vaccines (2021)
Epke A Le Rutte, Luc E Coffeng, Stefano Malvolti, Paul M Kaye, Sake J de Vlas
The potential impact of human visceral leishmaniasis vaccines on population incidence. PLoS neglected tropical diseases 14 (7) (2020)

Stefano Malvolti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stefano Malvolti